Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Scienture Holdings, Inc. before investing.

In this article, we go over a few key elements for understanding Scienture Holdings, Inc.’s stock price such as:

• Scienture Holdings, Inc.’s current stock price and volume
• Why Scienture Holdings, Inc.’s stock price changed recently
• Upgrades and downgrades for SCNX from analysts
• SCNX’s stock price momentum as measured by its relative strength

About Scienture Holdings, Inc. (SCNX)

Before we jump into Scienture Holdings, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is headquartered in Commack, New York.

Want to learn more about Scienture Holdings, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Scienture Holdings, Inc..

Scienture Holdings, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Scienture Holdings, Inc.’s stock price was $0.381.

Scienture Holdings, Inc. is down 0.29% from its previous closing price of $0.382.

During the last market session, Scienture Holdings, Inc.’s stock traded between $0.367 and $0.390. Currently, there are approximately 40.63 million shares outstanding for Scienture Holdings, Inc..

Scienture Holdings, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Scienture Holdings, Inc. Stock Price History

Scienture Holdings, Inc.’s (SCNX) price is currently up 8.77% so far this month.

During the month of July, Scienture Holdings, Inc.’s stock price has reached a high of $0.420 and a low of $0.290.

Over the last year, Scienture Holdings, Inc. has hit prices as high as $2.600 and as low as $0.238. Year to date, Scienture Holdings, Inc.’s stock is down 25.35%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Scienture Holdings, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded Scienture Holdings, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Scienture Holdings, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Scienture Holdings, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Scienture Holdings, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Scienture Holdings, Inc. (SCNX) by visiting AAII Stock Evaluator.

Relative Price Strength of Scienture Holdings, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Scienture Holdings, Inc. has a weighted four-quarter relative price strength of -27.60%, which translates to a Momentum Score of 8 and is considered to be Very Weak.

Want to learn more about how Scienture Holdings, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Scienture Holdings, Inc. Stock Price: Bottom Line

As of July 31, 2026, Scienture Holdings, Inc.’s stock price is $0.381, which is down 0.29% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Scienture Holdings, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.